Competitive PCR–ELISA combines competitive PCR with an ELISA to allow quantitative detection of PCR products. It is based on the inclusion of an internal standard competitor molecule that is designed ...

Budapest, HU – 6 January 2021 – Life Science Newswire – ZTA Biotech, a Budapest-based biotech startup has announced the breakthrough development of a COVID-19 antibody (IgG) test using the ELISA ...

Laboratory automation typically involves integrating key instrumentation with liquid- and microplate-handling robots creating workcells that are often designed for a single protocol. The scheduling ...

The ELISA (enzyme-linked immunosorbent assay) is a valuable and adaptable tool for researchers in global biochemistry, molecular biology, and diagnostics. It is a simple and efficient assay for ...

BOSTON & LONDON--(BUSINESS WIRE)--Synthace Ltd, the company behind Antha, the cloud-based software platform for automating and improving the success rate of biological processes, has launched a new ...

Abcam, a Danaher company and a global provider of validated antibodies and assay solutions, today announced SimpleStep Ignite™ ELISA, a next generation chemiluminescent immunoassay platform designed ...

Synthace Ltd, the company behind Antha, the cloud-based software platform for automating and improving the success rate of biological processes, has launched a new software capability for streamlining ...

There are many instances within the life sciences where detection and quantification of antigens or antibodies within a sample in a timely and cost-effective manner is important. From identifying ...

BRANCHBURG, N.J., June 5, 2020 /PRNewswire/ -- ZEUS Scientific announced today the submission for an Emergency Use Authorization (EUA) to the U.S. Food and Drug Administration (FDA) for its in vitro ...

First developed in 1992, immuno-PCR combines an ELISA (enzyme-linked immunosorbent assay) with PCR (polymerase chain reaction) to offer a significant increase in sensitivity compared with traditional ...

By expanding access to validated VEGF ELISA kits, Boster Bio aims to support more consistent data generation in serum-based ...

Myeloperoxidase (MPO) is a circulating cardiovascular disease (CVD) biomarker used to estimate clinical risk and patient prognosis. Current enzyme-linked immunosorbent assays (ELISA) for MPO ...